BRIEF published on 06/14/2024 at 09:09, 5 months 7 days ago IVU Traffic Technologies AG Announces Share Buyback Program Share Buyback Stock Exchange Investment IVU Traffic Technologies AG Financial Program
PRESS RELEASE published on 06/14/2024 at 09:04, 5 months 7 days ago EQS-Adhoc: IVU Traffic Technologies AG decides to buy back shares IVU Traffic Technologies AG announces share buyback program following approval from Annual General Meeting. The company plans to repurchase up to 100,000 shares on the stock exchange Annual General Meeting Share Repurchase Share Buyback Stock Exchange IVU Traffic Technologies AG
BRIEF published on 05/30/2024 at 14:48, 5 months 21 days ago Bert Meerstadt Appointed Chairman of IVU Traffic Technologies AG Annual General Meeting Supervisory Board Appointment IVU Traffic Technologies AG Bert Meerstadt
PRESS RELEASE published on 05/30/2024 at 14:43, 5 months 21 days ago IVU Traffic Technologies AG: Bert Meerstadt appointed Chairman of Supervisory Board Bert Meerstadt appointed Chairman of Supervisory Board at IVU Traffic Technologies AG following re-election at the Annual General Meeting Annual General Meeting Supervisory Board Chairman IVU Traffic Technologies AG Bert Meerstadt
BRIEF published on 05/28/2024 at 12:37, 5 months 24 days ago IVU Traffic Technologies AG Reports Strong Q1-2024 Performance Revenue Growth EBIT Gross Profit Q1-2024 IVU Traffic Technologies
PRESS RELEASE published on 05/28/2024 at 12:32, 5 months 24 days ago IVU Quarterly Report Q1-2024 IVU Traffic Technologies AG reports 18% increase in revenue and 11% increase in gross profit in Q1-2024. Operating profit slightly up year-on-year Revenue Increase Operating Profit IVU Traffic Technologies AG Q1-2024 Gross Profit Increase
BRIEF published on 03/21/2024 at 13:34, 8 months ago IVU Traffic Technologies Achieves Record Financial Performance in 2023 Financial Results Dividend Increase Annual Report 2023 IVU Traffic Technologies AG Public Transport Solutions
PRESS RELEASE published on 03/21/2024 at 13:29, 8 months ago IVU achieves record results in the 2023 fiscal year IVU Traffic Technologies AG achieves record results in the 2023 fiscal year with revenue up by 8.2% to €122.5 million. Increased dividend of €0.26 proposed at Annual General Meeting Revenue Increase Dividend Proposal 2023 Fiscal Year Record Results IVU Traffic Technologies AG
PRESS RELEASE published on 09/08/2023 at 09:26, 1 year 2 months ago EQS-Adhoc: IVU Traffic Technologies AG extends share buyback
PRESS RELEASE published on 08/23/2023 at 12:17, 1 year 2 months ago IVU AG publishes Half-year report 2023
Published on 11/21/2024 at 13:00, 36 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 36 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 36 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 36 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 36 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 1 hour 1 minute ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 21 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 38 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 16 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 51 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 51 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
